Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
insuline isophane humaine, 100 unités/mL, cartouche de 3 mL de suspension injectable |
Is a |
Isophane insulin preparation |
false |
Inferred relationship |
Some |
|
|
insuline isophane humaine, 100 unités/mL, cartouche de 3 mL de suspension injectable |
Is a |
Human insulin-containing product |
false |
Inferred relationship |
Some |
|
|
insuline isophane humaine, 100 unités/mL, cartouche de 3 mL de suspension injectable |
Is a |
Product containing intermediate-acting insulin |
false |
Inferred relationship |
Some |
|
|
insuline isophane humaine, 100 unités/mL, cartouche de 3 mL de suspension injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pancreatic hormone |
false |
Inferred relationship |
Some |
|
|
insuline isophane humaine, 100 unités/mL, cartouche de 3 mL de suspension injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Human insulin |
false |
Inferred relationship |
Some |
|
|
insuline isophane humaine, 100 unités/mL, cartouche de 3 mL de suspension injectable |
Is a |
Product containing human isophane insulin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
insuline isophane humaine, 100 unités/mL, cartouche de 3 mL de suspension injectable |
Has manufactured dose form |
injection |
false |
Inferred relationship |
Some |
|
|
insuline isophane humaine, 100 unités/mL, cartouche de 3 mL de suspension injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Isophane insulin |
false |
Inferred relationship |
Some |
|
|
insuline isophane humaine, 100 unités/mL, cartouche de 3 mL de suspension injectable |
Is a |
Product manufactured as parenteral dose form (product) |
false |
Inferred relationship |
Some |
|
|
insuline isophane humaine, 100 unités/mL, cartouche de 3 mL de suspension injectable |
Has manufactured dose form |
Suspension for injection |
false |
Inferred relationship |
Some |
|
|